The ERA Registry Annual Report 2019: summary and age comparisons
Background Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry...
| Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2022 |
| Country: | España |
| Institution: | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) |
| Repository: | r-FISABIO. Repositorio Institucional de Producción Científica |
| OAI Identifier: | oai:fisabio.fundanetsuite.com:p13747 |
| Online Access: | https://fisabio.portalinvestigacion.com/publicaciones/13747 |
| Access Level: | Open access |
| Keyword: | dialysis epidemiology ESRD graft survival kidney transplantation patient survival |
| id |
ES_dbdca2b72191567afab03cdb35fd23cb |
|---|---|
| oai_identifier_str |
oai:fisabio.fundanetsuite.com:p13747 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The ERA Registry Annual Report 2019: summary and age comparisonsBoenink RAstley MEHuijben JAStel VSKerschbaum JOts-Rosenberg MÅsberg AALopot FGolan ECastro de la Nuez PRodríguez Camblor MTrujillo-Alemán SRuiz San Millan JCUcio Mingo PDíaz JMBouzas-Caamaño MEArtamendi MAparicio Madre MISantiuste de Pablos CSlon Roblero MFZurriaga OStendahl MEBell SIdrizi AIoannou KDebska-Slizien AGalvão AADe Meester JMResic HHommel KRadunovic DPálsson RLassalle MFinne PDe Los Ángeles-Garcia Bazaga MGjorgjievski NSeyahi NBonthuis MOrtiz AJager KJKramer AdialysisepidemiologyESRDgraft survivalkidney transplantationpatient survivalBackground Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Methods Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. Results In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were >= 65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities.OXFORD UNIV PRESS2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/13747Clinical Kidney JournalISSN: 20488505ISSNe: 20488513reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Inglésinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p137472026-06-11T12:45:17Z |
| dc.title.none.fl_str_mv |
The ERA Registry Annual Report 2019: summary and age comparisons |
| title |
The ERA Registry Annual Report 2019: summary and age comparisons |
| spellingShingle |
The ERA Registry Annual Report 2019: summary and age comparisons Boenink R dialysis epidemiology ESRD graft survival kidney transplantation patient survival |
| title_short |
The ERA Registry Annual Report 2019: summary and age comparisons |
| title_full |
The ERA Registry Annual Report 2019: summary and age comparisons |
| title_fullStr |
The ERA Registry Annual Report 2019: summary and age comparisons |
| title_full_unstemmed |
The ERA Registry Annual Report 2019: summary and age comparisons |
| title_sort |
The ERA Registry Annual Report 2019: summary and age comparisons |
| dc.creator.none.fl_str_mv |
Boenink R Astley ME Huijben JA Stel VS Kerschbaum J Ots-Rosenberg M Åsberg AA Lopot F Golan E Castro de la Nuez P Rodríguez Camblor M Trujillo-Alemán S Ruiz San Millan JC Ucio Mingo P Díaz JM Bouzas-Caamaño ME Artamendi M Aparicio Madre MI Santiuste de Pablos C Slon Roblero MF Zurriaga O Stendahl ME Bell S Idrizi A Ioannou K Debska-Slizien A Galvão AA De Meester JM Resic H Hommel K Radunovic D Pálsson R Lassalle M Finne P De Los Ángeles-Garcia Bazaga M Gjorgjievski N Seyahi N Bonthuis M Ortiz A Jager KJ Kramer A |
| author |
Boenink R |
| author_facet |
Boenink R Astley ME Huijben JA Stel VS Kerschbaum J Ots-Rosenberg M Åsberg AA Lopot F Golan E Castro de la Nuez P Rodríguez Camblor M Trujillo-Alemán S Ruiz San Millan JC Ucio Mingo P Díaz JM Bouzas-Caamaño ME Artamendi M Aparicio Madre MI Santiuste de Pablos C Slon Roblero MF Zurriaga O Stendahl ME Bell S Idrizi A Ioannou K Debska-Slizien A Galvão AA De Meester JM Resic H Hommel K Radunovic D Pálsson R Lassalle M Finne P De Los Ángeles-Garcia Bazaga M Gjorgjievski N Seyahi N Bonthuis M Ortiz A Jager KJ Kramer A |
| author_role |
author |
| author2 |
Astley ME Huijben JA Stel VS Kerschbaum J Ots-Rosenberg M Åsberg AA Lopot F Golan E Castro de la Nuez P Rodríguez Camblor M Trujillo-Alemán S Ruiz San Millan JC Ucio Mingo P Díaz JM Bouzas-Caamaño ME Artamendi M Aparicio Madre MI Santiuste de Pablos C Slon Roblero MF Zurriaga O Stendahl ME Bell S Idrizi A Ioannou K Debska-Slizien A Galvão AA De Meester JM Resic H Hommel K Radunovic D Pálsson R Lassalle M Finne P De Los Ángeles-Garcia Bazaga M Gjorgjievski N Seyahi N Bonthuis M Ortiz A Jager KJ Kramer A |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
dialysis epidemiology ESRD graft survival kidney transplantation patient survival |
| topic |
dialysis epidemiology ESRD graft survival kidney transplantation patient survival |
| description |
Background Data on renal replacement therapy (RRT) for end-stage renal disease were collected by the European Renal Association (ERA) Registry via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article provides a summary of the 2019 ERA Registry Annual Report, including data from 34 countries and additional age comparisons. Methods Individual patient data for 2019 were provided by 35 registries and aggregated data by 17 registries. Using these data, the incidence and prevalence of RRT, the kidney transplantation activity and the survival probabilities were calculated. Results In 2019, a general population of 680.8 million people was covered by the ERA Registry. Overall, the incidence of RRT was 132 per million population (p.m.p.). Of these patients, 62% were men, 54% were >= 65 years of age and 21% had diabetes mellitus as primary renal disease (PRD), and 84% had haemodialysis (HD), 11% had peritoneal dialysis (PD) and 5% had pre-emptive kidney transplantation as an initial treatment modality. The overall prevalence of RRT on 31 December 2019 was 893 p.m.p., with 58% of patients on HD, 5% on PD and 37% living with a kidney transplant. The overall kidney transplant rate was 35 p.m.p. and 29% of the kidney grafts were from a living donor. The unadjusted 5-year survival probability was 42.3% for patients commencing dialysis, 86.6% for recipients of deceased donor grafts and 94.4% for recipients of living donor grafts in the period 2010-14. When comparing age categories, there were substantial differences in the distribution of PRD, treatment modality and kidney donor type, and in the survival probabilities. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://fisabio.portalinvestigacion.com/publicaciones/13747 |
| url |
https://fisabio.portalinvestigacion.com/publicaciones/13747 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
OXFORD UNIV PRESS |
| publisher.none.fl_str_mv |
OXFORD UNIV PRESS |
| dc.source.none.fl_str_mv |
Clinical Kidney Journal ISSN: 20488505 ISSNe: 20488513 reponame:r-FISABIO. Repositorio Institucional de Producción Científica instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) |
| instname_str |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) |
| reponame_str |
r-FISABIO. Repositorio Institucional de Producción Científica |
| collection |
r-FISABIO. Repositorio Institucional de Producción Científica |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869421715139854336 |
| score |
15.812429 |